請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62412
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 郭明良(Min-Liang Kuo) | |
dc.contributor.author | Tsai-Ning Lin | en |
dc.contributor.author | 林才甯 | zh_TW |
dc.date.accessioned | 2021-06-16T16:02:14Z | - |
dc.date.available | 2018-09-24 | |
dc.date.copyright | 2013-09-24 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-07-08 | |
dc.identifier.citation | Andreas, H., R. Sara, and P. Pim. 2010. Perturbation of the yeast N-acetyltransferase NatB induces elevation of protein phosphorylation levels.
Arnesen, T. 2011. Towards a functional understanding of protein N-terminal acetylation. Plos Biol. 9:e1001074. Arnesen, T., D. Anderson, C. Baldersheim, M. Lanotte, J.E. Varhaug, and J.R. Lillehaug. 2005. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Biochem J. 386:433-443. Arnesen, T., M.J. Betts, F. Pendino, D.A. Liberles, D. Anderson, J. Caro, X. Kong, J.E. Varhaug, and J.R. Lillehaug. 2006a. Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase. Bmc Biochem. 7:13. Arnesen, T., D. Gromyko, F. Pendino, A. Ryningen, J. Varhaug, and J. Lillehaug. 2006b. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex. Oncogene. 25:4350-4360. Arnesen, T., P.R. Thompson, J.E. Varhaug, and J.R. Lillehaug. 2008. The Protein Acetyltransferase ARD1: A Novel Cancer Drug Target? Curr Cancer Drug Tar. 8:545-553. Arnesen, T., P. Van Damme, B. Polevoda, K. Helsens, R. Evjenth, N. Colaert, J.E. Varhaug, J. Vandekerckhove, J.R. Lillehaug, F. Sherman, and K. Gevaert. 2009. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. P Natl Acad Sci USA. 106:8157-8162. Asaumi, M., K. Iijima, A. Sumioka, K. Iijima-Ando, Y. Kirino, T. Nakaya, and T. Suzuki. 2005. Interaction of N-terminal acetyltransferase with the cytoplasmic domain of beta-amyloid precursor protein and its effect on A beta secretion. J Biochem. 137:147-155. Bilton, R., N. Mazure, E. Trottier, M. Hattab, M.A. Dery, D.E. Richard, J. Pouyssegur, and M.C. Brahimi-Horn. 2005. Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1 alpha and is not induced by hypoxia or HIF. J Biol Chem. 280:31132-31140. Bilton, R., E. Trottier, J. Pouyssegur, and M.C. Brahimi-Horn. 2006. ARDent about acetylation and deacetylation in hypoxia signalling. Trends Cell Biol. 16:616-621. Brown, S.E., R.D. Campbell, and C.M. Sanderson. 2001. Novel NG36/G9a gene products encoded within the human and mouse MHC class III regions. Mamm Genome. 12:916-924. Chen, M.W., K.T. Hua, H.J. Kao, C.C. Chi, L.H. Wei, G. Johansson, S.G. Shiah, P.S. Chen, Y.M. Jeng, T.Y. Cheng, T.C. Lai, J.S. Chang, Y.H. Jan, M.H. Chien, C.J. Yang, M.S. Huang, M. Hsiao, and M.L. Kuo. 2010. H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM. Cancer Res. 70:7830-7840. Dillon, S.C., X. Zhang, R.C. Trievel, and X. Cheng. 2005. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 6:227. Ding, N., H. Zhou, P.O. Esteve, H.G. Chin, S. Kim, X. Xu, S.M. Joseph, M.J. Friez, C.E. Schwartz, S. Pradhan, and T.G. Boyer. 2008. Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. Mol Cell. 31:347-359. Dong, C.F., Y.D. Wu, J. Yao, Y.F. Wang, Y.H. Yu, P.G. Rychahou, B.M. Evers, and B.P. Zhou. 2012. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest. 122:1469-1486. Driessen, H.P., W.W. de Jong, G.I. Tesser, and H. Bloemendal. 1985. The mechanism of N-terminal acetylation of proteins. CRC critical reviews in biochemistry. 18:281-325. Epsztejn-Litman, S., N. Feldman, M. Abu-Remaileh, Y. Shufaro, A. Gerson, J. Ueda, R. Deplus, F. Fuks, Y. Shinkai, H. Cedar, and Y. Bergman. 2008. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol. 15:1176-1183. Esteller, M. 2005. Aberrant DNA methylation as a cancer-inducing mechanism. Annu. Rev. Pharmacol. Toxicol. 45:629-656. Esteve, P.O., D. Patnaik, H.G. Chin, J. Benner, M.A. Teitell, and S. Pradhan. 2005. Functional analysis of the N- and C-terminus of mammalian G9a histone H3 methyltransferase. Nucleic Acids Res. 33:3211-3223. Fisher, T.S., S. Des Etages, L. Hayes, K. Crimin, and B.Y. Li. 2005. Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J Biol Chem. 280:17749-17757. Gauci, S., A.O. Helbig, M. Slijper, J. Krijgsveld, A.J.R. Heck, and S. Mohammed. 2009. Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Analytical chemistry. 81:4493-4501. Gautschi, M., S. Just, A. Mun, S. Ross, P. Rucknagel, Y. Dubaquie, A. Ehrenhofer-Murray, and S. Rospert. 2003. The yeast N-alpha-acetyltransferase NatA is quantitatively anchored to the ribosome and interacts with nascent polypeptides. Mol Cell Biol. 23:7403-7414. Gupta-Agarwal, S., A.V. Franklin, T. DeRamus, M. Wheelock, R.L. Davis, L.L. McMahon, and F.D. Lubin. 2012. G9a/GLP Histone Lysine Dimethyltransferase Complex Activity in the Hippocampus and the Entorhinal Cortex Is Required for Gene Activation and Silencing during Memory Consolidation. J Neurosci. 32:5440-5453. Hanahan, D., and R.A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell. 144:646-674. He, Y.L., I. Korboukh, J. Jin, and J. Huang. 2012. Targeting protein lysine methylation and demethylation in cancers. Acta Bioch Bioph Sin. 44:70-79. Helsens, K., P. Van Damme, S. Degroeve, L. Martens, T. Arnesen, J. Vandekerckhove, and K. Gevaert. 2011. Bioinformatics analysis of a Saccharomyces cerevisiae N-terminal proteome provides evidence of alternative translation initiation and post-translational N-terminal acetylation. J Proteome Res. Hershko, A., H. Heller, E. Eytan, G. Kaklij, and I.A. Rose. 1984. Role of the alpha-amino group of protein in ubiquitin-mediated protein breakdown. Proc Natl Acad Sci U S A. 81:7021-7025. Hua, K.T., C.T. Tan, G. Johansson, J.M. Lee, P.W. Yang, H.Y. Lu, C.K. Chen, J.L. Su, P.B. Chen, Y.L. Wu, C.C. Chi, H.J. Kao, H.J. Shih, M.W. Chen, M.H. Chien, P.S. Chen, W.J. Lee, T.Y. Cheng, G. Rosenberger, C.Y. Chai, C.J. Yang, M.S. Huang, T.C. Lai, T.Y. Chou, M. Hsiao, and M.L. Kuo. 2011. N-alpha-Acetyltransferase 10 Protein Suppresses Cancer Cell Metastasis by Binding PIX Proteins and Inhibiting Cdc42/Rac1 Activity. Cancer Cell. 19:218-231. Huang, J., J. Dorsey, S. Chuikov, L. Perez-Burgos, X.Y. Zhang, T. Jenuwein, D. Reinberg, and S.L. Berger. 2010. G9a and Glp methylate lysine 373 in the tumor suppressor p53 (vol 285, pg 9636, 2010). J Biol Chem. 285:18122-18122. Jeong, J.W., M.K. Bae, M.Y. Ahn, S.H. Kim, T.K. Sohn, M.H. Bae, M.A. Yoo, E.J. Song, K.J. Lee, and K.W. Kim. 2002. Regulation and destabilization of HIF-1 alpha by ARD1-mediated acetylation. Cell. 111:709-720. Jones, P.A., and S.B. Baylin. 2007. The epigenomics of cancer. Cell. 128:683-692. Kalvik, T.V., and T. Arnesen. 2012. Protein N-terminal acetyltransferases in cancer. Oncogene. Kondo, Y., L. Shen, S. Ahmed, Y. Boumber, Y. Sekido, B.R. Haddad, and J.P.J. Issa. 2008. Downregulation of Histone H3 Lysine 9 Methyltransferase G9a Induces Centrosome Disruption and Chromosome Instability in Cancer Cells. Plos One. 3. Krueger, K.E., and S. Srivastava. 2006. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteomics. 5:1799-1810. Kuo, H.P., and M.C. Hung. 2010. Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein? Am J Transl Res. 2:56-64. Kuo, H.P., D.F. Lee, C.T. Chen, M. Liu, C.K. Chou, H.J. Lee, Y. Du, X.M. Xie, Y.K. Wei, W.Y. Xia, W.H. Zhang, J.Y. Yang, C.J. Yen, T.H. Huang, M.J. Tan, G. Xing, Y.M. Zhao, C.H. Lin, S.F. Tsai, I.J. Fidler, and M.C. Hung. 2010. ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway. Sci Signal. 3. Lee, C.F., D.S. Ou, S.B. Lee, L.H. Chang, R.K. Lin, Y.S. Li, A.K. Upadhyay, X. Cheng, Y.C. Wang, H.S. Hsu, M. Hsiao, C.W. Wu, and L.J. Juan. 2010. hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest. 120:2920-2930. Li, H., X. Xing, G. Ding, Q. Li, C. Wang, L. Xie, R. Zeng, and Y. Li. 2009. SysPTM: a systematic resource for proteomic research on post-translational modifications. Molecular & Cellular Proteomics. 8:1839-1849. Lim, J.H., Y.S. Chun, and J.W. Park. 2008. Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin. Cancer Res. 68:5177-5184. Lim, J.H., J.W. Park, and Y.S. Chun. 2006. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res. 66:10677-10682. Ling, B.M.T., N. Bharathy, T.K. Chung, W.K. Kok, S. Li, Y.H. Tan, V.K. Rao, S. Gopinadhan, V. Sartorelli, M.J. Walsh, and R. Taneja. 2012. Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. P Natl Acad Sci USA. 109:841-846. Maze, I., H.E. Covington, D.M. Dietz, Q. LaPlant, W. Renthal, S.J. Russo, M. Mechanic, E. Mouzon, R.L. Neve, S.J. Haggarty, Y.H. Ren, S.C. Sampath, Y.L. Hurd, P. Greengard, A. Tarakhovsky, A. Schaefer, and E.J. Nestler. 2010. Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity. Science. 327:213-216. Mazo, A.M., D.H. Huang, B.A. Mozer, and I.B. Dawid. 1990. The trithorax gene, a trans-acting regulator of the bithorax complex in Drosophila, encodes a protein with zinc-binding domains. Proceedings of the National Academy of Sciences. 87:2112. Milner, C.M., and R.D. Campbell. 1993. The G9a Gene in the Human Major Histocompatibility Complex Encodes a Novel Protein Containing Ankyrin-Like Repeats (Vol 290, Pg 811, 1993). Biochem J. 292:952-952. Nagano, T., J.A. Mitchell, L.A. Sanz, F.M. Pauler, A.C. Ferguson-Smith, R. Feil, and P. Fraser. 2008. The Air Noncoding RNA Epigenetically Silences Transcription by Targeting G9a to Chromatin. Science. 322:1717-1720. Nishida, M., M. Kato, Y. Kato, N. Sasai, J. Ueda, M. Tachibana, Y. Shinkai, and M. Yamaguchi. 2007. Identification of ZNF200 as a novel binding partner of histone H3 methyltransferase G9a. Genes Cells. 12:877-888. Ohkawa, N., S. Sugisaki, E. Tokunaga, K. Fujitani, T. Hayasaka, M. Setou, and K. Inokuchi. 2008. N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development. Genes Cells. 13:1171-1183. Park, E.C., and J.W. Szostak. 1992. Ard1 and Nat1 Proteins Form a Complex That Has N-Terminal Acetyltransferase Activity. Embo J. 11:2087-2093. Polevoda, B., T. Arnesen, and F. Sherman. 2009. A synopsis of eukaryotic Nα-terminal acetyltransferases: nomenclature, subunits and substrates. Vol. 3. BioMed Central Ltd. S2. Polevoda, B., and F. Sherman. 2000. Nalpha -terminal acetylation of eukaryotic proteins. J Biol Chem. 275:36479-36482. Purcell, D.J., K.W. Jeong, D. Bittencourt, D.S. Gerke, and M.R. Stallcup. 2011. A Distinct Mechanism for Coactivator versus Corepressor Function by Histone Methyltransferase G9a in Transcriptional Regulation. J Biol Chem. 286:41963-41971. Rea, S., F. Eisenhaber, D. O'Carroll, B.D. Strahl, Z.W. Sun, M. Schmid, S. Opravil, K. Mechtler, C.P. Ponting, and C.D. Allis. 2000. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 406:593-599. Ren, T.T., B.H. Jiang, G.L. Jin, J.N. Li, B. Dong, J.Z. Zhang, L. Meng, J. Wu, and C.C. Shou. 2008. Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer. Cancer Lett. 264:83-92. Robin, P., L. Fritsch, O. Philipot, F. Svinarchuk, and S. Ait-Si-Ali. 2007. Post-translational modifications of histones H3 and H4 associated with the histone methyltransferases Suv39h1 and G9a. Genome Biol. 8. Rope, A.F., K. Wang, R. Evjenth, J.C. Xing, J.J. Johnston, J.J. Swensen, W.E. Johnson, B. Moore, C.D. Huff, L.M. Bird, J.C. Carey, J.M. Opitz, C.A. Stevens, T. Jiang, C. Schank, H.D. Fain, R. Robison, B. Dalley, S. Chin, S.T. South, T.J. Pysher, L.B. Jorde, H. Hakonarson, J.R. Lillehaug, L.G. Biesecker, M. Yandell, T. Arnesen, and G.J. Lyon. 2011. Using VAAST to Identify an X-Linked Disorder Resulting in Lethality in Male Infants Due to N-Terminal Acetyltransferase Deficiency. Am J Hum Genet. 89:28-43. Rual, J.F., K. Venkatesan, T. Hao, T. Hirozane-Kishikawa, A. Dricot, N. Li, G.F. Berriz, F.D. Gibbons, M. Dreze, and N. Ayivi-Guedehoussou. 2005. Towards a proteome-scale map of the human protein–protein interaction network. Nature. 437:1173-1178. Sampath, S.C., I. Marazzi, K.L. Yap, S.C. Sampath, A.N. Krutchinsky, I. Mecklenbrauker, A. Viale, E. Rudensky, M.M. Zhou, B.T. Chait, and A. Tarakhovsky. 2007. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol Cell. 27:596-608. Seo, J.H., J.H. Cha, J.H. Park, C.H. Jeong, Z.Y. Park, H.S. Lee, S.H. Oh, J.H. Kang, S.W. Suh, K.H. Kim, J.Y. Ha, S.H. Han, S.H. Kim, J.W. Lee, J.A. Park, J.W. Jeong, K.J. Lee, G.T. Oh, M.N. Lee, S.W. Kwon, S.K. Lee, K.H. Chun, S.J. Lee, and K.W. Kim. 2010. Arrest Defective 1 Autoacetylation Is a Critical Step in Its Ability to Stimulate Cancer Cell Proliferation. Cancer Res. 70:4422-4432. Sharma, S., D.S. Gerke, H.F. Han, S.W. Jeong, M.R. Stallcup, P.A. Jones, and G.N. Liang. 2012. Lysine methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated nucleosomes and maintenance of DNA methylation in somatic cells. Epigenet Chromatin. 5. Shinkai, Y., and M. Tachibana. 2011. H3K9 methyltransferase G9a and the related molecule GLP. Gene Dev. 25:781-788. Sugiura, N., S.M. Adams, and R.A. Corriveau. 2003. An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development. J Biol Chem. 278:40113-40120. Tachibana, M., Y. Matsumura, M. Fukuda, H. Kimura, and Y. Shinkai. 2008. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. Embo J. 27:2681-2690. Tachibana, M., K. Sugimoto, T. Fukushima, and Y. Shinkai. 2001. SET domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem. 276:25309-25317. Takahashi, A., Y. Imai, K. Yamakoshi, S. Kuninaka, N. Ohtani, S. Yoshimoto, S. Hori, M. Tachibana, E. Anderton, T. Takeuchi, Y. Shinkai, G. Peters, H. Saya, and E. Hara. 2012. DNA Damage Signaling Triggers Degradation of Histone Methyltransferases through APC/C-Cdh1 in Senescent Cells. Mol Cell. 45:123-131. Van Damme, P., R. Evjenth, H. Foyn, K. Demeyer, P.J. De Bock, J.R. Lillehaug, J. Vandekerckhove, T. Arnesen, and K. Gevaert. 2011. Proteome-derived peptide libraries allow detailed analysis of the substrate specificities of N(alpha)-acetyltransferases and point to hNaa10p as the post-translational actin N(alpha)-acetyltransferase. Mol Cell Proteomics. 10:M110 004580. Wang, Z., J. Guo, Y. Li, J.H. Bavarva, C. Qian, M.C. Brahimi-Horn, D. Tan, and W. Liu. 2012. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis. Proc Natl Acad Sci U S A. 109:3053-3058. Xu, H., B. Jiang, L. Meng, T. Ren, Y. Zeng, J. Wu, L. Qu, and C. Shou. 2012. N-alpha-Acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression. Carcinogenesis. Yang, X.J., and E. Seto. 2008. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell. 31:449-461. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62412 | - |
dc.description.abstract | 在癌症發展中,特定的蛋白質轉譯後修飾作用會促進基因表現或靜默,進而調控癌細胞的生長。真核生物中最普遍的共價修飾作用為N端乙醯化修飾,藉由特定N端乙醯基轉移酶來催化轉移百分之八十至九十的人類蛋白質乙醯基。其中,Naa10p為具催化N端乙醯化修飾能力的酵素反應次單元,能進行N端α氮及ε氮上之乙醯基轉移,亦可催化自乙醯化,已知參與許多細胞內功能調控。近年許多研究顯示Naa10p異常對癌細胞的發展有關,但在癌細胞中Naa10p扮演的角色仍不清楚。另一調控因子G9a,主要是催化DNA組蛋白H3上第九個胺基酸離胺酸(Lysine 9)進行甲基化的甲基轉移酶,進而抑制某些腫瘤抑制基因的轉錄而促使癌症發生。先前本實驗室研究發現G9a高度表現在末期惡性癌症病人的腫瘤組織中,認為G9a為一致癌基因。2005年Rual et al利用高通量酵母菌兩蛋白質雜交系統指出Naa10p與G9a之間會交互作用。因此在本篇研究中,我們試圖確認Naa10p與G9a的交互作用與兩者之間結合位置,更進一步想了解此兩酵素結合後會發生甚麼樣的調控作用。有趣的是,我們發現當過度表現Naa10p時,會顯著的抑制G9a甲基轉移能力,同樣的當靜默Naa10p時,G9a催化之H3K9二甲基化會顯著的增加。綜合以上實驗結果,顯示G9a會在N端以及Cys-ANK 重複序列聯結之間與Naa10p之N端58個胺基酸序列之間交互作用,並受到Naa10p調控而失去催化H3K9二甲基化的酵素活性。我們也利用transwell的細胞遷移實驗,指出Naa10p及G9a之間的確會有一條控的角色存在。未來可進一步研究Naa10p對G9a的蛋白質交互作用調控機制,並多加探討G9a是否會藉由調控Naa10p而影響下游轉錄轉譯基因改變,以便於未來有機會能運用在癌症之臨床檢測與治療上。 | zh_TW |
dc.description.abstract | Specific combinations of post-translational modifications of proteins facilitating gene transcription or silencing and play an important role in regulating tumor progression. One of the most common covalent modifications in eukaryotes is N-terminal acetylation (Nt-acetylation), by specific acetyltransferase catalyzing the transfer of acetyl moieties to the N-termini of 80-90% of all human proteins. Human N-α-acetyltransferas 10 protein (Naa10p), the catalytic subunit of N-acetyltransferase A, catalyzes both N-α-acetylation and ε-acetylation, as well as autoacetylation and is involved in a variety of cellular functions and. Some studies shows that dysregulation of Naa10p is associated with tumorigenesis, however it plays a conflict role and the biological functions remains largely unknown. Another regulated factor, DNA Histone 3 Lysine 9 (H3K9) methyltransferase G9a can promote tumor metastasis by repressing downstream tumor suppressor genes. Our previous studies demonstrated that G9a is highly expressed in late stage aggressive cancer patients and has been identify it as an oncoprotein. In 2005, Rual et al. reported that Naa10p will interact with G9a by a high-throughput yeast two-hybrid system. In this study, we confirm the interaction between Naa10p and G9a and also evaluate the binding domain among each other. Interestingly, we found that enforced expression of Naa10p significantly impaired the G9a enzyme activity, whereas Naa10p silencing increased H3K9 dimethyltransferase activity. We also used transwell migration assay to indicate that there is a regulated role between Naa10p and G9a. Our study indicated that Naa10p functions as a suppressor of the oncogenic protein G9a. We hypothesize that the protein-protein interaction functions and mechanisms between Naa10p and G9a is possible to anticipate novel anticancer drugs in the future. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T16:02:14Z (GMT). No. of bitstreams: 1 ntu-102-R99447008-1.pdf: 1393463 bytes, checksum: 3867911fab331289067dbf98af2320dd (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 中文摘要.....................................1
Abstract....................................3 Introduction................................5 Materials and Methods......................11 Results....................................22 Discussion.................................28 Figures and Figure Legends.................34 Reference..................................47 | |
dc.language.iso | en | |
dc.title | 探討N端乙醯基轉移酶與H3K9組蛋白甲基轉移酶G9a在癌細胞腫瘤發生中扮演的角色 | zh_TW |
dc.title | Evaluation of the role between N-α-acetyltransferase 10 protein (Naa10p) and H3K9 histone methyltransferase G9a in cancer cell tumorigenesis | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 林明燦(Ming-Tsan Lin),蕭宏昇(Michael Hsiao),嚴孟祿(Men-Luh Yen) | |
dc.subject.keyword | 蛋白質轉譯後修飾,N端乙醯基轉移酶,組蛋白甲基轉移酶,蛋白質交互作用, | zh_TW |
dc.subject.keyword | Post-translational modifications,N-acetyltransferase,Histone methyltransferase,Protein-Protein interaction, | en |
dc.relation.page | 53 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2013-07-08 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 毒理學研究所 | zh_TW |
顯示於系所單位: | 毒理學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 1.36 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。